EQS: latest releases

• Hapag-Lloyd AG shareholders approved today with the required majority all items on the agenda put to the vote at the virtual Annual General Meeting.
• This included the appropriation of the net profit and thereby the payment of a dividend of EUR 1.10 per share.
• The shareholders also approved the proposal of the Supervisory Board to elect Dr Isabella Niklas to the Supervisory Board as a shareholder representative.
• All voting results of today's Annual General Meeting can be viewed in the Investor Relations section of the Hapag-Lloyd website at https://www.hapag-lloyd.com/en/ir/calendar-events/annual-general-meeting....

• Dissemination of a Regulatory Announcement, transmitted by EQS Group.
• The issuer is solely responsible for the content of this announcement.
• Press Release | Krasnodar | June 5, 2020
  Krasnodar, Russia (June 5, 2020): Magnit PJSC (MOEX and LSE: MGNT; Company, Group), one of Russia's leading retailers, notifies on the transactions by persons discharging managerial responsibilities and persons closely associated with them.

• The issuer is solely responsible for the content of this announcement.
• The Company's AGM was held today at 11.00 BST.
• As at the close of business on 4 June 2020, the Company had62,826,963 ordinary shares of 0.01 each in issue (with no shares held in treasury).
• The final votes received in respect of each resolution put to the meeting were as set out below.

• Corestate Capital Holding S.A. (Corestate), a leading European real estate investment manager, today elected a new Supervisory Board at its online Annual General Meeting.
• Dr. Georg Allendorf, Dr. Gabriele Apfelbacher, Timothy Blackwell, Marc Drieen and Olaf Klinger have been appointed members of the Supervisory Board.
• At the subsequent constituent meeting, Dr. Georg Allendorf was unanimously elected the new Chairman of the Supervisory Board, Timothy Blackwell as his Deputy and Olaf Klinger as Chairman of the Audit Committee.
• Furthermore, the enlargement of the Supervisory Board goes hand in hand with a consistent evolution of our standards in corporate governance and transparency."

Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

• Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
• If none, this should be stated.

• On June 3, 2020 the audited stand-alone and consolidated financial statements of Petro Welt Technologies AG (PeWeTe) were approved by resolution of the company's Supervisory Board.
• Following a recommendation of the Management Board the Supervisory Board also decided not to recommend a distribution of profits but to carry profits forward into 2020.
• The financial statements can be found on PeWeTe's corporate website www.pewete.com.
• Petro Welt Technologies AG, which is domiciled in Vienna is one of the leading and first established OFS companies in Russia and the CIS and is specialized in services which increase the productivity of new as well as existing oil & gas formations.

• AiCuris was Granted Breakthrough Therapy Designation by U.S. FDA for Pritelivir for the Treatment of HSV Infections in Immunocompromised Patients
  The issuer is solely responsible for the content of this announcement.
• AiCuris was Granted Breakthrough Therapy Designation by U.S. FDA for Pritelivir for the Treatment of HSV Infections in Immunocompromised Patients
  Wuppertal, June 05, 2020 - AiCuris Anti-infective Cures GmbH, a leading company in the discovery and development of drugs against infectious diseases, today announced that the Company has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for oral pritelivir, AiCuris' lead candidate for the treatment of acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections in immunocompromised adults.
• foscarnet, a virostatic agent which is used mainly for the treatment of HSV resistant to other antiviral drugs.
• With the Breakthrough Therapy designation, AiCuris reached an important milestone and is now looking for a partner for the further development of pritelivir.

• Branch event finds innovative solution for August 7, 2020
  eno energy has not only been established as an innovative medium-sized company in the wind energy plant production for years, but also finds creative solutions in the event sector to implement the current health policy requirements for Rostock Wind in August.
• 6, 18055 Rostock) with 50 guests and
  the planning forum / finances as usual in the Radisson Blue Hotel (Lange Str.
• Also the captains of the Artemis and Loth Lorien are looking forward to the pleasant and evening networking on the Warnow with the guests of Rostock Wind.
• We are pleased to organize this unique event with our partners and to welcome you on 07.08.2020 in Rostock.

• In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail.
• We declare that our above statements are in conformity with the principles included in the Board's Communiqu, Serial II Nr.15.1, that it exactly reflects the information we received; that the information complies with our records, books and documents; that we did our best to obtain the correct and complete information relative to this subject and that we are responsible for the declarations made in this regard.

• Such redemptions will be free of redemption charge up to the Last Trading Date.
• From the day after the Last Trading Date to the Liquidation Date, no further subscriptions and redemptions will be accepted.
• Please note that the Company does not charge any redemption charge (the "Redemption Charge") for the sale of Shares in the secondary market.
• Following the liquidation of the Sub-Fund, the liquidation proceeds will be distributed to the remaining shareholders proportionnally to the number of Shares held by each shareholder prior to the liquidation.

• World Brain Tumor Day occures every year on June 8th to raise awareness and inspire hope for patients living with this disease.
• Glioblastoma is the most common and aggressive form of brain tumors in adults with an incidence, i.e.
• Additionally, many other types of cancer cause metastases in the brain, which are known as secondary brain tumors.
• Alivia Cancer Foundation, SPSK4 Hospital in Lublin and MagForce invite you to a webinar for patients on the occasion of World Brain Tumor Day.

• Sberbank releases Financial Highlights for 5 months of 2020 (under RAS; non-consolidated)
  Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
• Sberbank releases Financial Highlights for 5 months of 2020 (under RAS; non-consolidated)
  The numbers are calculated in accordance with Sberbank's internal methodology.
• Please note that some minor changes became effective in Sberbank's internal methodology starting from January 1, 2020.
• Sberbank is vigorously supporting people and companies through both its own and state programs, primarily for mortgages and small and medium businesses.

• Oberhaching / Ascheberg, June 5, 2020 - The drilling technology and geothermal energy group Daldrup & Shne (ISIN DE0007830572) has successfully drilled the first well of the triplet for Aardwarmte Combinatie Luttelgeest B.V., Luttelgeest (ACL), Netherlands.
• For greenhouse operators, this increases the profitability of the heating plant and shortens the payback period.
• Daldrup & Shne AG expects this to become the new standard in Dutch geothermal projects.
• GERF B.V., a 100 % subsidiary of Daldrup & Shne AG, will drill the second of a total of three wells ordered from mid-June onwards.

• 11 / 2020) with a leading global product manufacturer in the USA
  The issuer is solely responsible for the content of this announcement.
• RIB Software SE (RIB) signs a Phase-II-contract (No.
• 11 / 2020) with a leading global product manufacturer in the USA
  Alpharetta, Georgia 5 June 2020.
• "At BSD SpecLink, we are committed to the continual improvement of the process used to design and specify commercial buildings.

• Under the leadership of board member Roberto Spano, the management of Pegasus Development AG has decided to further expand Pegastril-Nuevo production facilities.
• New production facilities will be set up at several locations across the world and the site in Turkey is being expanded.
• Pegasus Development AG promptly secured the exclusive rights by investing in Nuevo, thereby developing the Pegastril-Nuevo brand.
• This will open up an immense market for Pegasus Development AG that promises tremendous growth.